Alyeska Investment Group
CVET

Alyeska Investment Group’s Covetrus, Inc. Common Stock CVET Stock Holding History

Alyeska Investment Group’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-88,102
Closed -$2.15M – 536
2019
Q2 		$2.15M Buy
+88,102
New +$2.54M 0.03% 314

Other funds holding CVET

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Alyeska Investment Group's CVET Position: Q3 2019 in Review

Alyeska Investment Group sold out of Covetrus, Inc. Common Stock (CVET) in Q3 2019, closing a stake of 88,102 shares — an estimated $2.15M sold.

Alyeska Investment Group first reported a position in CVET in Q2 2019 and held it in 1 quarter. The position peaked at $2.15M in Q2 2019. 282 funds tracked by Wall St. Rank hold CVET as of Q3 2019.

  • Alyeska Investment Group reported no remaining Covetrus, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Alyeska Investment Group sold 88,102 Covetrus, Inc. Common Stock shares in Q3 2019, an estimated $2.15M.
  • Alyeska Investment Group first reported a position in Covetrus, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • Alyeska Investment Group's Covetrus, Inc. Common Stock position peaked at $2.15M in Q2 2019.
  • 282 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q3 2019.

Based on Alyeska Investment Group's 13F filing for Q3 2019, filed 14 Nov 2019.